| Symbol | PINE |
|---|---|
| Name | ALPINE INCOME PROPERTY TRUST, INC. |
| Sector | REAL ESTATE |
| Region | North America |
| Industry | - |
| Address | 32789 United States FL 369 N. New York Avenue Suite 201 |
| Telephone | (407) 904-3324 |
| Fax | — |
| — | |
| Website | https://www.alpinereit.com/ |
| Incorporation | US |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;NASDAQ |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001786117 |
| Description | Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The companys proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202. Additional info from NASDAQ: |
Richardson Andrew C 🔴 sold 2.0K shares of Alpine Income Property Trust, Inc. (PINE) at $20.28 Transaction Date: Jul 28, 2026 | Filing ID: 000015
Read more📋 Richardson Andrew C (Director) plans to sell 2K shares of Alpine Income Property Trust, Inc. (at $20.20 each, total $40K) Filed: Jul 28, 2026 | ID: 005414
Read more(30% Negative) ALPINE INCOME PROPERTY TRUST, INC. (PINE) Reports Q3 2026 Financial Results
Read more